ATAI
NASDAQ · Pharmaceuticals
Ataibeckley Inc
$7.25
+0.07 (+0.97%)
Open$7.20
Previous Close$7.18
Day High$7.25
Day Low$7.20
52W High$7.22
52W Low$3.27
Volume—
Avg Volume11.13M
Market Cap2.68B
P/E Ratio—
EPS$-2.23
SectorPharmaceuticals
Analyst Ratings
Hold
21 analysts
Price Target
+457.8% upside
Current
$7.25
$7.25
Target
$40.44
$40.44
$27.58
$40.44 avg
$50.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.73M | 2.70M | 436.73M |
| Net Income | -1,083,916,484 | -1,191,899,115 | 64.85M |
| Profit Margin | -16,142.0% | -46,040.8% | 14.9% |
| EBITDA | -1,044,669,757 | -1,216,403,523 | 102.81M |
| Free Cash Flow | — | — | 81.44M |
| Rev Growth | +161.0% | -75.3% | -6.2% |
| Debt/Equity | — | 0.20 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |